The global Oral Solid Dosage (OSD) Pharmaceutical Formulation Market, valued at US$ 654.6 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2034, reaching US$ 1.1 billion by 2034. OSD formulations, including tablets, capsules, and granules, are the most common drug delivery systems due to their stability, ease of administration, and...